171 related articles for article (PubMed ID: 22391184)
1. [Homing characteristics of graft cells in leukemia mice after allogenic bone marrow transplantation with different conditioning regimens].
Chen CP; Chen ZZ; Huang HF; Cai XY; He HX; Wu ZC; Luo XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):137-41. PubMed ID: 22391184
[TBL] [Abstract][Full Text] [Related]
2. [Injury of bone marrow endothelial niche by irradiation myeloablative conditioning in mouse allo-BMT].
Tang RX; Ding S; Xu KL; Jia L; Yan ZL; Chen C; Zeng LY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1579-84. PubMed ID: 21176374
[TBL] [Abstract][Full Text] [Related]
3. [Study on nonmyeloablative allogeneic bone marrow transplantation in the treatment of L615 leukemia mice].
Xu KL; Ju JP; Pan XY; Du B; Li ZY; Lu QX
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):372-5. PubMed ID: 12941194
[TBL] [Abstract][Full Text] [Related]
4. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
[TBL] [Abstract][Full Text] [Related]
5. [Application of low dose of fludarabine and cyclophosphamide combined with donor NK Cells as a non-myeloablative conditioning regimen for the haploidentical hematopoietic stem cell transplantation in mice].
Yu JP; Cao S; Xin N; An XM; Qi J; Ren XB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1013-8. PubMed ID: 17956681
[TBL] [Abstract][Full Text] [Related]
6. Nonmyeloablative conditioning regimens and bone marrow transplantation--some contemporary aspects.
Gocheva LB
Folia Med (Plovdiv); 2010; 52(1):12-7. PubMed ID: 20380282
[TBL] [Abstract][Full Text] [Related]
7. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
[TBL] [Abstract][Full Text] [Related]
8. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
9. [Induction of immune tolerance for allogenic recipient mice by non-myeloablative bone marrow transplantation].
Chen BA; Bi YZ; Ding JH; Zhang Y; Gao C; Sun YY; Zhao G; Wang J; Cheng J; Sun XM; Schmitt M; Döhner H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1054-7. PubMed ID: 16403279
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of leukemia with immunized donor cell infusion after nonmyeloablative haploidentical bone marrow transplantation].
Xu PF; Duan LN; Luo Y; Wang Z; Lu CR; Xiang PD; Lei YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):711-5. PubMed ID: 23815928
[TBL] [Abstract][Full Text] [Related]
11. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
12. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
13. [Study on the mechanism of enhancing homing efficiency of human hematopoietic stem/progenitor cells into bone marrow after manipulation with tumor necrosis factor alpha in xenotransplanted BALB/c mouse model].
Dai HS; Gao JT; Zhang TW; Yang Z; Che YZ; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):97-102. PubMed ID: 19563019
[TBL] [Abstract][Full Text] [Related]
14. Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice.
Cui YZ; Hisha H; Yang GX; Fan TX; Jin T; Li Q; Lian Z; Ikehara S
Bone Marrow Transplant; 2002 Dec; 30(12):843-9. PubMed ID: 12476275
[TBL] [Abstract][Full Text] [Related]
15. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
[TBL] [Abstract][Full Text] [Related]
16. Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice.
Nilsson C; Forsman J; Hassan Z; Abedi-Valugerdi M; O'Connor C; Concha H; Jansson M; Hassan M
Exp Hematol; 2005 Mar; 33(3):380-7. PubMed ID: 15730862
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
Du B; Li DP; Xu KL; Pan XY
Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte colony-stimulating factor prior to nonmyeloablative irradiation decreases murine host hematopoietic stem cell function and increases engraftment of donor marrow cells.
Barese C; Pech N; Dirscherl S; Meyers JL; Sinn AL; Yoder MC; Goebel WS; Dinauer MC
Stem Cells; 2007 Jun; 25(6):1578-85. PubMed ID: 17347493
[TBL] [Abstract][Full Text] [Related]
19. Distribution of marrow repopulating cells between bone marrow and spleen early after transplantation.
Plett PA; Frankovitz SM; Orschell CM
Blood; 2003 Sep; 102(6):2285-91. PubMed ID: 12775569
[TBL] [Abstract][Full Text] [Related]
20. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]